- Investing Ideas
- Swedish Pharmaceuticals & Biotech Healthy potentially undervalued
Swedish Pharmaceuticals & Biotech Healthy potentially undervalued
Results
4
Companies which are potentially undervalued and in an acceptable financial position.
4 companies
Camurus
Market Cap: SEK 34.3b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 577.00
7D
6.1%
1Y
-6.7%
Swedish Orphan Biovitrum
Market Cap: SEK 161.9b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 468.20
7D
-0.6%
1Y
64.1%
Vitrolife
Market Cap: SEK 12.1b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 89.60
7D
1.9%
1Y
-37.4%
Bonesupport Holding
Market Cap: SEK 13.8b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 210.00
7D
4.1%
1Y
-26.6%